(Q34926571)

5 August 2017

1 reference

title

Finding a role for PML in APL pathogenesis: a critical assessment of potential PML activities (English)

1 reference

5 August 2017

S Strudwick

1

1 reference

5 August 2017

K L B Borden

series ordinal

2

1 reference

5 August 2017

publication date

1 October 2002

1 reference

5 August 2017

1 reference

5 August 2017

volume

16

1 reference

5 August 2017

issue

10

1 reference

5 August 2017

page(s)

1906-1917

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2402724

5 August 2017

exact match

0 references

cites work

The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

15/17 translocation, a consistent chromosomal change in acute promyelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Acute promyelocytic leukemia: from treatment to genetics and back

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

PML, a growth suppressor disrupted in acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Histone deacetylases: a common molecular target for differentiation treatment of acute myeloid leukemias?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

The promyelocytic leukemia protein PML has a pro-apoptotic activity mediated through its RING domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Cell-cycle regulation of DNA damage-induced expression of the suppressor gene PML

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Analysis of the growth and transformation suppressor domains of promyelocytic leukemia gene, PML.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Recombinant PML adenovirus suppresses growth and tumorigenicity of human breast cancer cells by inducing G1 cell cycle arrest and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

PML RING suppresses oncogenic transformation by reducing the affinity of eIF4E for mRNA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

PML is essential for multiple apoptotic pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

The PML nuclear bodies: actors or extras?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Review: properties and assembly mechanisms of ND10, PML bodies, or PODs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Role of PML in cell growth and the retinoic acid pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Pondering the promyelocytic leukemia protein (PML) puzzle: possible functions for PML nuclear bodies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

RING domains: master builders of molecular scaffolds?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Construction of macromolecular assemblages in eukaryotic processes and their role in human disease: linking RINGs together

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Characterization of a Zinc Finger Gene Disrupted by the t(15;17) in Acute Promyelocytic Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

The solution structure of the RING finger domain from the acute promyelocytic leukaemia proto-oncoprotein PML

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

In vivo and in vitro characterization of the B1 and B2 zinc-binding domains from the acute promyelocytic leukemia protooncoprotein PML

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

PML protein isoforms and the RBCC/TRIM motif

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Cellular proteins localized at and interacting within ND10/PML nuclear bodies/PODs suggest functions of a nuclear depot

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

The promyelocytic leukemia (PML) protein suppresses cyclin D1 protein production by altering the nuclear cytoplasmic distribution of cyclin D1 mRNA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Nuclear domain 10 (ND10) associated proteins are also present in nuclear bodies and redistribute to hundreds of nuclear sites after stress

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

DNA viruses and viral proteins that interact with PML nuclear bodies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Role and fate of PML nuclear bodies in response to interferon and viral infections

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Orchestration of multiple arrays of signal cross-talk and combinatorial interactions for maturation and cell death: another vision of t(15;17) preleukemic blast and APL-cell maturation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Maturation sensitive and resistant t(15;17) NB4 cell lines as tools for APL physiopathology: nomenclature of cells and repertory of their known genetic alterations and phenotypes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Functional interaction of p53 and BLM DNA helicase in apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Visualization of gene activity in living cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

The promyelocytic leukemia protein PML interacts with the proline-rich homeodomain protein PRH: a RING may link hematopoiesis and growth control

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

SUMO--nonclassical ubiquitin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

The RING domains of the promyelocytic leukemia protein PML and the arenaviral protein Z repress translation by directly inhibiting translation initiation factor eIF4E.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

PML-containing nuclear bodies: their spatial distribution in relation to other nuclear components

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Nuclear domains enriched in RNA 3'-processing factors associate with coiled bodies and histone genes in a cell cycle-dependent manner

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

The 35-kDa mammalian splicing factor SC35 mediates specific interactions between U1 and U2 small nuclear ribonucleoprotein particles at the 3' splice site

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Cajal bodies: the first 100 years

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

P53 and PML: new partners in tumor suppression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

PML interaction with p53 and its role in apoptosis and replicative senescence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

PML and the oncogenic nuclear domains in regulating transcriptional repression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

The promyelocytic (PML) nuclear compartment and transcription control

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Transcriptional repression by the promyelocytic leukemia protein, PML.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

The transcription coactivator CBP is a dynamic component of the promyelocytic leukemia nuclear body

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

PML regulates p53 acetylation and premature senescence induced by oncogenic Ras

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Role of PML and PML-RARalpha in Mad-mediated transcriptional repression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Combinatorial roles of the nuclear receptor corepressor in transcription and development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Translational regulation of ribonucleotide reductase by eukaryotic initiation factor 4E links protein synthesis to the control of DNA replication

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

The mRNA 5' cap-binding protein eIF4E and control of cell growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

A fraction of the mRNA 5' cap-binding protein, eukaryotic initiation factor 4E, localizes to the nucleus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Coupled transcription and translation within nuclei of mammalian cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Cooperative modulation by eIF4G of eIF4E-binding to the mRNA 5' cap in yeast involves a site partially shared by p20.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Repressor binding to a dorsal regulatory site traps human eIF4E in a high cap-affinity state

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

The emerging roles of translation factor eIF4E in the nucleus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Nuclear eukaryotic initiation factor 4E (eIF4E) colocalizes with splicing factors in speckles

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Stabilization of eukaryotic initiation factor 4E binding to the mRNA 5'-Cap by domains of eIF4G.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Quantitative assessment of mRNA cap analogues as inhibitors of in vitro translation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Translational regulation of vascular permeability factor by eukaryotic initiation factor 4E: implications for tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Eukaryotic translation initiation factor 4E regulates expression of cyclin D1 at transcriptional and post-transcriptional levels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Translational control of programmed cell death: eukaryotic translation initiation factor 4E blocks apoptosis in growth-factor-restricted fibroblasts with physiologically expressed or deregulated Myc.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 mRNA are increased in cells overexpressing eukaryotic initiation factor 4E.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

eIF4G dramatically enhances the binding of eIF4E to the mRNA 5'-cap structure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Defect in the regulation of 4E-BP1 and 2, two repressors of translation initiation, in the retinoid acid resistant cell lines, NB4-R1 and NB4-R2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Exclusion of Int-6 from PML nuclear bodies by binding to the HTLV-I Tax oncoprotein.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Molecular cloning of a new interferon-induced PML nuclear body-associated protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Demonstration of a RNA-dependent nuclear interaction between the promyelocytic leukaemia protein and glyceraldehyde-3-phosphate dehydrogenase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

The human interferon- and estrogen-regulated ISG20/HEM45 gene product degrades single-stranded RNA and DNA in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Glyceraldehyde-3-phosphate dehydrogenase selectively binds AU-rich RNA in the NAD(+)-binding region (Rossmann fold).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Sequence-specific binding of transfer RNA by glyceraldehyde-3-phosphate dehydrogenase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Nuclear distribution of prothymosin alpha and parathymosin: evidence that prothymosin alpha is associated with RNA synthesis processing and parathymosin with early DNA replication

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Telomerase can inhibit the recombination-based pathway of telomere maintenance in human cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Immunohistochemical expression and pathogenesis of BLM in the human brain and visceral organs.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

The distribution and expression of the Bloom's syndrome gene product in normal and neoplastic human cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Nuclear structure in normal and Bloom syndrome cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Localization of the Bloom syndrome helicase to punctate nuclear structures and the nuclear matrix and regulation during the cell cycle: comparison with the Werner's syndrome helicase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

An arenavirus RING (zinc-binding) protein binds the oncoprotein promyelocyte leukemia protein (PML) and relocates PML nuclear bodies to the cytoplasm.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Cytoplasmic recruitment of INI1 and PML on incoming HIV preintegration complexes: interference with early steps of viral replication

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

RING for destruction?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Repression of cap-dependent translation by 4E-binding protein 1: competition with p220 for binding to eukaryotic initiation factor-4E

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Triggering of neuronal cell death by accumulation of activated SEK1 on nuclear polyglutamine aggregations in PML bodies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Self-assembly properties of a model RING domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Role of the promyelocytic leukemia protein PML in the interferon sensitivity of lymphocytic choriomeningitis virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Accumulation and intranuclear distribution of unintegrated human immunodeficiency virus type 1 DNA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

The completed sequence of lymphocytic choriomeningitis virus reveals a unique RNA structure and a gene for a zinc finger protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

The lymphocytic choriomeningitis virus RING protein Z associates with eukaryotic initiation factor 4E and selectively represses translation in a RING-dependent manner

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product (ICP0).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Specific destruction of kinetochore protein CENP-C and disruption of cell division by herpes simplex virus immediate-early protein Vmw110.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Alphaherpesvirus proteins related to herpes simplex virus type 1 ICP0 affect cellular structures and proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

ICP0 induces the accumulation of colocalizing conjugated ubiquitin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Structure, organization, and dynamics of promyelocytic leukemia protein nuclear bodies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

eIF4E expression in tumors: its possible role in progression of malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Expression of the eukaryotic translation initiation factors 4E and 2alpha in non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Elevated expression of eIF4E in confined early breast cancer lesions: possible role of hypoxia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Detection of the Proto-oncogene eIF4E in Larynx and Hypopharynx Cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Clinical outcome in stage I to III breast carcinoma and eIF4E overexpression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

A PMLRARalpha transgene initiates murine acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Multiple roles of the tumor suppressor p53.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Identification of the gal4 suppressor Sug1 as a subunit of the yeast 26S proteasome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Gamma interferon and cadmium treatments modulate eukaryotic initiation factor 4E-dependent mRNA transport of cyclin D1 in a PML-dependent manner

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402724

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2402724

1 reference

Dimensions Publication ID

5 August 2017

1011640738

0 references

1 reference